CORDIS
EU research results

CORDIS

English EN
Scaling up the WHO-PEN package for diabetes and hypertension in Swaziland: a nation-wide cluster-randomised evaluation of three strategies in Swaziland (WHO-PEN@Scale)

Scaling up the WHO-PEN package for diabetes and hypertension in Swaziland: a nation-wide cluster-randomised evaluation of three strategies in Swaziland (WHO-PEN@Scale)

Objective

Swaziland has a very high prevalence of both diabetes and hypertension, with the majority of those affected being undiagnosed. Like many other countries in sub-Saharan Africa (SSA), however, Swaziland provides care for diabetes and hypertension only through physician-led teams in hospitals. The country has recently conducted a successful feasibility pilot of the World Health Organisation’s Package of Essential NCD Interventions for Primary Health Care in low-resource settings (WHO-PEN). The WHO-PEN@Scale project aims to improve diabetes and hypertension control at the population-level by helping Swaziland identify and scale up the most effective healthcare delivery model for WHO-PEN implementation at scale. Specifically, we will conduct an innovative nation-wide three-phased adaptive randomised study to i) rigorously assess the effectiveness and cost-effectiveness of three novel community-based healthcare delivery models to scale up WHO-PEN for diabetes and hypertension nationally, ii) study in-depth the real-life implementation of the WHO-PEN national scale-up in Swaziland to generate lessons for other countries, and iii) actively disseminate the Swazi experience along with an open-source toolkit for WHO-PEN scale-up to policy makers in SSA. WHO-PEN@Scale will therefore provide a blueprint of primary health system strengthening for diabetes and hypertension – and ultimately non-communicable diseases (NCDs) more generally - for other countries in the region. WHO-PEN@Scale is highly relevant to this work programme because i) the interventions contained in WHO-PEN have been shown to be cost-effective, ii) the scale-up is government-led, and iii) we assess the impact of WHO-PEN@Scale on diabetes and hypertension control at the population-level.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITATSKLINIKUM HEIDELBERG

Address

Im Neuenheimer Feld 672
69120 Heidelberg

Germany

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 648 750

Participants (8)

Sort alphabetically

Sort by EU Contribution

Expand all

SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT

Switzerland

EU Contribution

€ 262 696,25

UNIVERSITY OF SWAZILAND

Eswatini

EU Contribution

€ 218 750

STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT

Netherlands

EU Contribution

€ 459 335

GEORG-AUGUST-UNIVERSITAT GOTTINGENSTIFTUNG OFFENTLICHEN RECHTS

Germany

EU Contribution

€ 320 070

FOLKEHELSEINSTITUTTET

Norway

EU Contribution

€ 224 018,25

CLINTON HEALTH ACCESS INITIATIVE

United States

EU Contribution

€ 1 222 042,50

DIABETES SWAZILAND

Eswatini

EU Contribution

€ 37 500

SWAZILAND BUSINESS COALITION ON HIVAND AIDS

Eswatini

EU Contribution

€ 56 250

Project information

Grant agreement ID: 825823

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    30 June 2023

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 3 449 412

  • EU contribution

    € 3 449 412

Coordinated by:

UNIVERSITATSKLINIKUM HEIDELBERG

Germany